… Targeting inflammation by using nanomedicines (ie nanoparticles loaded with … treatment
of inflammatory diseases. After providing a brief insight on the pathophysiology of inflammation …

… drug ready for treatment of diseases in acute … for inflammatory diseases. Several phase III
clinical trials for treatment of acute Graft Versus Host Disease (GVHD) and Crohn’s disease are …

… many inflammatory … inflammatory diseases, IL-1 and TNF- are the important cytokines that
can induce the expression of NF-B which is the potential target in these inflammatory diseases. …

… disease. This review focuses on the current treatments for inflammatory bowel disease.
Keywords: inflammatory bowel disease (lED), 5-aminosalicylates, cOliicosteroids, infliximab …

… Therefore anti-inflammatory therapy is a very promising strategy for the prevention …
treatment of these inflammatory diseases. To overcome the shortcomings of existing anti-inflammatory …

… target for treatment of RA, while we will also illustrate the potential problems of inhibiting
NF-κB for the treatment of septic shock. A well studied paradigm for chronic inflammation is RA, …

… , although human inflammatory cell activity … treatment of a range of inflammatory diseases,
including asthma, chronic obstructive pulmonary disease (COPD), inflammatory bowel disease…

… the p38 MAPK inhibitors that have been demonstrated to prevent diseases in vitro and in
vivo. This review summarizes p38 MAPK inhibitors used for inflammatory diseases and cancer. …

… inhibitors for the treatment for other inflammatory diseases. Whether the … inflammatory
disease, on the extent of inflammation and its aggressiveness. In vitro and in vivo anti-inflammatory …

… neonatal-onset multisystem inflammatory disease are caused by gain-of-… inflammatory
process 5 . NLRP3 has also been implicated in the pathogenesis of a number of complex diseases…